Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Raw Materials (2023 - 2025)

SRx Health Solutions (SRXH) has disclosed Raw Materials for 3 consecutive years, with $542000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Raw Materials fell 31.22% year-over-year to $542000.0, compared with a TTM value of $542000.0 through Sep 2025, down 31.22%, and an annual FY2025 reading of $542000.0, changed N/A over the prior year.
  • Raw Materials was $542000.0 for Q3 2025 at SRx Health Solutions, down from $550000.0 in the prior quarter.
  • Across five years, Raw Materials topped out at $1.1 million in Q4 2023 and bottomed at $542000.0 in Q3 2025.
  • Average Raw Materials over 3 years is $749666.7, with a median of $752500.0 recorded in 2024.
  • The sharpest move saw Raw Materials plummeted 31.27% in 2024, then crashed 31.22% in 2025.
  • Year by year, Raw Materials stood at $1.1 million in 2023, then tumbled by 31.27% to $765000.0 in 2024, then fell by 29.15% to $542000.0 in 2025.
  • Business Quant data shows Raw Materials for SRXH at $542000.0 in Q3 2025, $550000.0 in Q2 2025, and $740000.0 in Q1 2025.